Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/17/2026 | $190.00 | Neutral → Buy | BofA Securities |
| 1/21/2026 | $205.00 | Hold → Buy | Truist |
| 1/20/2026 | $200.00 | Hold → Buy | HSBC Securities |
| 1/13/2026 | $185.00 | Hold → Buy | Deutsche Bank |
| 1/12/2026 | $200.00 | Sector Perform → Sector Outperform | Scotiabank |
| 1/7/2026 | $210.00 | Neutral → Outperform | Robert W. Baird |
| 12/16/2025 | $147.00 | Underweight → Equal-Weight | Morgan Stanley |
| 12/5/2025 | $185.00 | Neutral → Buy | UBS |
10-K - ALBEMARLE CORP (0000915913) (Filer)
8-K - ALBEMARLE CORP (0000915913) (Filer)
SCHEDULE 13G/A - ALBEMARLE CORP (0000915913) (Subject)
4 - ALBEMARLE CORP (0000915913) (Issuer)
4 - ALBEMARLE CORP (0000915913) (Issuer)
4 - ALBEMARLE CORP (0000915913) (Issuer)
BofA Securities upgraded Albemarle from Neutral to Buy and set a new price target of $190.00
Truist upgraded Albemarle from Hold to Buy and set a new price target of $205.00
HSBC Securities upgraded Albemarle from Hold to Buy and set a new price target of $200.00
CHARLOTTE, N.C., Feb. 26, 2026 /PRNewswire/ -- The Board of Directors of Albemarle Corporation (NYSE:ALB) today announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2026, to shareholders of record at the close of business as of March 13, 2026. About Albemarle Albemarle Corporation (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protec
Decision improves financial flexibility and preserves optionality CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced it will idle the remaining operating train, Train 1, at its Kemerton lithium hydroxide processing plant in Western Australia and place it into care and maintenance effective immediately. Today's announcement follows actions in 2024 to place Train 2 into care and maintenance and to cease expansion plans for Trains 3 and 4.
CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Results and Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Fourth quarter net sales of $1.4 billion, up 16%; volume up 12%, including gains in all segments led by Energy Storage (up 17%) and Ketjen (up 13%).Fourth quarter net loss of
4 - ALBEMARLE CORP (0000915913) (Issuer)
CHARLOTTE, N.C., Feb. 26, 2026 /PRNewswire/ -- The Board of Directors of Albemarle Corporation (NYSE:ALB) today announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2026, to shareholders of record at the close of business as of March 13, 2026. About Albemarle Albemarle Corporation (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protec
Decision improves financial flexibility and preserves optionality CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced it will idle the remaining operating train, Train 1, at its Kemerton lithium hydroxide processing plant in Western Australia and place it into care and maintenance effective immediately. Today's announcement follows actions in 2024 to place Train 2 into care and maintenance and to cease expansion plans for Trains 3 and 4.
CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Results and Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Fourth quarter net sales of $1.4 billion, up 16%; volume up 12%, including gains in all segments led by Energy Storage (up 17%) and Ketjen (up 13%).Fourth quarter net loss of
Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi
Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr
CHARLOTTE, N.C., Aug. 2, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $2.4 billion, an increase of 60%Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%Adjusted diluted EPS of $7.33, an increase of 112%Adjusted EBITDA of $1.0 billion, an i
SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)
SC 13G - ALBEMARLE CORP (0000915913) (Subject)
SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)